Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1

Interventions

Cyclophosphamide 27fludarabine phosphate 26Mycophenolic Acid 22Tacrolimus 17Busulfan 17Antilymphocyte Serum 17Peripheral Blood Stem Cell Transplantation 16Whole-Body Irradiation 15Methotrexate 15Melphalan 15Filgrastim 15Cyclosporine 15thymoglobulin 10fludarabine 10Methylprednisolone 9Thiotepa 8Radiotherapy 8Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Cytarabine 7Cord Blood Stem Cell Transplantation 7Etoposide 6Clofarabine 6Rituximab 5Sirolimus 4Antibodies 4Alemtuzumab 4Flow Cytometry 3Azacitidine 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myelomonocytic, Juvenile × Radioimmunotherapy × Clear all
NCT04082286 2021-06-25

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Great Ormond Street Hospital for Children NHS Foundation Trust

Phase 1 Completed
9 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡